Brainstorm Cell Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCLI and other ETFs, options, and stocks.About BCLI
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function.
CEOChaim Lebovits
CEOChaim Lebovits
Employees29
Employees29
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2000
Founded2000
Employees29
Employees29
BCLI Key Statistics
Market cap29.50M
Market cap29.50M
Price-Earnings ratio-1.06
Price-Earnings ratio-1.06
Dividend yield—
Dividend yield—
Average volume710.37K
Average volume710.37K
High today$0.535
High today$0.535
Low today$0.41
Low today$0.41
Open price$0.44
Open price$0.44
Volume1.92M
Volume1.92M
52 Week high$3.34
52 Week high$3.34
52 Week low$0.134
52 Week low$0.134